How nanomedicine and AI are teaming up to tackle neurodegenerative diseases‎

When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders are not caused by a single malfunction in the system, but rather by a cascade of failures, which includes protein misfolding, synaptic breakdown, impaired repair mechanisms and poor drug delivery across the blood-brain barrier.